NEW YORK (
) is trading at unusually high volume Thursday with 603,712 shares changing hands. It is currently at four times its average daily volume and trading up 69 cents (+3.5%) at $20.50 as of 3:46 p.m. ET.
Hi-Tech Pharmacal has a market cap of $250.6 million and is part of the
industry. Shares are down 20.6% year to date as of the close of trading on Wednesday.
Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States. The company has a P/E ratio of 7.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.5.
TheStreet Ratings rates Hi-Tech Pharmacal as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
See all heavy volume stocks in our
or get investment ideas from our